Canada markets closed

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.4580+0.0130 (+2.92%)
At close: 04:00PM EDT
0.4800 +0.02 (+4.80%)
After hours: 04:40PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
5,181
5,181
2,509
1,618
23.02
Cost of Revenue
201.879
201.879
370.394
328.118
86.712
Gross Profit
4,979
4,979
2,138
1,290
-63.692
Operating Expenses
Research Development
181.907
181.907
300.789
590.476
6,555
Selling General and Administrative
12,228
12,228
9,624
8,851
6,429
Total Operating Expenses
12,410
12,410
9,924
9,442
12,984
Operating Income or Loss
-7,431
-7,431
-7,786
-8,152
-13,047
Interest Expense
500
500
500
500.05
112.994
Total Other Income/Expenses Net
-
-
-
105.13
-
Income Before Tax
-7,792
-7,792
-8,224
-8,538
-13,155
Income from Continuing Operations
-7,792
-7,792
-8,224
-8,538
-13,155
Net Income
-7,792
-7,792
-8,224
-8,538
-13,155
Net Income available to common shareholders
-7,792
-7,792
-8,224
-8,538
-13,155
Basic EPS
-2.27
-2.33
-2.62
-3.18
-6.24
Diluted EPS
-2.27
-2.33
-2.62
-3.18
-6.24
Basic Average Shares
3,343
3,343
3,144
2,682
2,124
Diluted Average Shares
3,343
3,343
3,144
2,682
2,124